Literature DB >> 16135862

Schizophrenia practice guidelines: international survey and comparison.

Wolfgang Gaebel1, Stefan Weinmann, Norman Sartorius, Wolfgang Rutz, John S McIntyre.   

Abstract

BACKGROUND: Schizophrenia guidelines differ considerably in methodology and content. AIMS: To systematically compare national schizophrenia guidelines from different countries.
METHOD: An international survey was conducted on guideline development and a methodological comparison was made using a validated guideline appraisal instrument (the Appraisal Guideline Research and Evaluation Europe).
RESULTS: The methodological quality of many schizophrenia guidelines was at best moderate. Few guidelines had included key stakeholders in their development process. Although pharmacotherapy recommendations were similar, there were strong variations in the type of psychosocial interventions recommended.
CONCLUSIONS: The methodological quality of guidelines has a strong influence on their applicability. However, the lack of financial means to develop and implement guidelines is a serious problem. Independent international organisations could contribute to defining a core set of unbiased schizophrenia treatment recommendations. In countries with a shortage of resources, this could be a basis for adaptation to different cultural and economic backgrounds in collaboration with stakeholders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16135862     DOI: 10.1192/bjp.187.3.248

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  52 in total

1.  Commentary: NICE--setting clinical standards.

Authors:  Gillian Leng; Michael Rawlins; Mercia Page
Journal:  BMJ       Date:  2007-05-19

2.  Implementing NICE guidance.

Authors:  Jayne Chidgey; Gillian Leng; Terence Lacey
Journal:  J R Soc Med       Date:  2007-10       Impact factor: 5.344

3.  A NICE mess.

Authors:  Susham Gupta; James Warner
Journal:  J R Soc Med       Date:  2007-10       Impact factor: 5.344

Review 4.  Racial and ethnic disparities in the use of antipsychotic medication: a systematic review and meta-analysis.

Authors:  Joseph H Puyat; Jamie R Daw; Colleen M Cunningham; Michael R Law; Sabrina T Wong; Devon L Greyson; Steven G Morgan
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-08-14       Impact factor: 4.328

5.  Stakeholder Perspectives on Implementing Cognitive Behavioral Social Skills Training on Assertive Community Treatment Teams.

Authors:  David H Sommerfeld; Gregory A Aarons; Jeanean B Naqvi; Jason Holden; Dimitri Perivoliotis; Kim T Mueser; Eric Granholm
Journal:  Adm Policy Ment Health       Date:  2019-03

6.  Side effects of atypical antipsychotics: a brief overview.

Authors:  Alp Uçok; Wolfgang Gaebel
Journal:  World Psychiatry       Date:  2008-02       Impact factor: 49.548

Review 7.  A translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacy.

Authors:  William G Honer; Ric M Procyshyn; Eric Y H Chen; G William MacEwan; Alasdair M Barr
Journal:  J Psychiatry Neurosci       Date:  2009-11       Impact factor: 6.186

8.  Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations.

Authors:  Hans-Jürgen Möller; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-02       Impact factor: 5.270

Review 9.  Antipsychotic medication for early episode schizophrenia.

Authors:  John Bola; Dennis Kao; Haluk Soydan
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

10.  Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study.

Authors:  Rune A Kroken; Erik Johnsen; Torleif Ruud; Tore Wentzel-Larsen; Hugo A Jørgensen
Journal:  BMC Psychiatry       Date:  2009-05-16       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.